FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022073464> ?p ?o ?g. }

• W2022073464 endingPage "1375" @default.
• W2022073464 startingPage "1361" @default.
• W2022073464 abstract "In recent years, progress has been made in cancer immunotherapy by the development of drugs acting as modulators of immune checkpoint proteins, such as the cytotoxic T-lymphocyte antigen-4 (CTLA4) and programmed death-1 (PD-1), two co-inhibitory receptors that are expressed on T cells upon activation. These molecules play crucial roles in maintaining immune homeostasis by down-regulating T-cell signaling, thereby preventing unbridled T-cell proliferation while maintaining tolerance to self-antigens, such as tumor-associated antigens. CTLA4 blockade through systemic administration of the CTLA4-blocking antibody ipilimumab was shown to confer significant survival benefit and prolonged stable disease in patients affected by advanced cutaneous melanoma. Other immune checkpoint inhibitors are under clinical evaluation. However, immune checkpoint blockade can lead to the breaking of immune self-tolerance, thereby inducing a novel syndrome of autoimmune/autoinflammatory side effects, designated as “immune-related adverse events,” mainly including rash, colitis, hepatitis, and endocrinopathies. We searched the medical literature using the words “hypophysitis,” “hypopituitarism,” “thyroid,” “adrenal insufficiency,” and “endocrine adverse events” in association with “immune checkpoint inhibitors,” “ipilimumab,” “tremelimumab,” “PD-1,” and “PD-1-L.” The spectrum of endocrine disease experienced by patients treated with ipilimumab includes most commonly hypophysitis, more rarely thyroid disease or abnormalities in thyroid function tests, and occasionally primary adrenal insufficiency. Hypophysitis has emerged as a distinctive side effect of CTLA4-blocking antibodies, establishing a new form of autoimmune pituitary disease. This condition, if not promptly recognized, may be life-threatening (due to secondary hypoadrenalism). Hypopituitarism caused by these agents is rarely reversible, and prolonged or lifelong substitutive hormonal treatment is often required. The precise mechanism of injury to the endocrine system triggered by these drugs is yet to be fully elucidated. Although reports of endocrine side effects caused by cancer immune therapy are abundant, their exact prevalence and mechanism are unclear. Well-designed correlative studies oriented to finding and validating predictive factors of autoimmune toxicity are urgently needed." @default.
• W2022073464 created "2016-06-24" @default.
• W2022073464 creator A5005594699 @default.
• W2022073464 creator A5042989547 @default.
• W2022073464 creator A5043026082 @default.
• W2022073464 creator A5056208360 @default.
• W2022073464 creator A5067097442 @default.
• W2022073464 creator A5085155842 @default.
• W2022073464 date "2013-04-01" @default.
• W2022073464 modified "2023-10-15" @default.
• W2022073464 title "Endocrine Side Effects Induced by Immune Checkpoint Inhibitors" @default.
• W2022073464 cites W1964977762 @default.
• W2022073464 cites W1965494873 @default.
• W2022073464 cites W1966999467 @default.
• W2022073464 cites W1967084952 @default.
• W2022073464 cites W1970860197 @default.
• W2022073464 cites W1976190556 @default.
• W2022073464 cites W1976336602 @default.
• W2022073464 cites W1978373343 @default.
• W2022073464 cites W1978721974 @default.
• W2022073464 cites W1981288213 @default.
• W2022073464 cites W1982086114 @default.
• W2022073464 cites W1982300885 @default.
• W2022073464 cites W1984545852 @default.
• W2022073464 cites W1985905844 @default.
• W2022073464 cites W1986358403 @default.
• W2022073464 cites W1987375369 @default.
• W2022073464 cites W1987419250 @default.
• W2022073464 cites W1988822265 @default.
• W2022073464 cites W1989823046 @default.
• W2022073464 cites W1992546156 @default.
• W2022073464 cites W1992771046 @default.
• W2022073464 cites W1996398553 @default.
• W2022073464 cites W1996583836 @default.
• W2022073464 cites W1996617450 @default.
• W2022073464 cites W1999365970 @default.
• W2022073464 cites W2002250199 @default.
• W2022073464 cites W2006091295 @default.
• W2022073464 cites W2007490054 @default.
• W2022073464 cites W2016789384 @default.
• W2022073464 cites W2017347750 @default.
• W2022073464 cites W2020727013 @default.
• W2022073464 cites W2025438854 @default.
• W2022073464 cites W2034378000 @default.
• W2022073464 cites W2036840935 @default.
• W2022073464 cites W2040851929 @default.
• W2022073464 cites W2041672829 @default.
• W2022073464 cites W2042035964 @default.
• W2022073464 cites W2044016891 @default.
• W2022073464 cites W2044363258 @default.
• W2022073464 cites W2049163935 @default.
• W2022073464 cites W2052796954 @default.
• W2022073464 cites W2054535181 @default.
• W2022073464 cites W2056085563 @default.
• W2022073464 cites W2061824209 @default.
• W2022073464 cites W2071523891 @default.
• W2022073464 cites W2074529340 @default.
• W2022073464 cites W2081521066 @default.
• W2022073464 cites W2085172491 @default.
• W2022073464 cites W2094366129 @default.
• W2022073464 cites W2095826876 @default.
• W2022073464 cites W2096060394 @default.
• W2022073464 cites W2097560051 @default.
• W2022073464 cites W2097995306 @default.
• W2022073464 cites W2098414192 @default.
• W2022073464 cites W2099651334 @default.
• W2022073464 cites W2100127605 @default.
• W2022073464 cites W2100919344 @default.
• W2022073464 cites W2101653483 @default.
• W2022073464 cites W2103220202 @default.
• W2022073464 cites W2107150019 @default.
• W2022073464 cites W2109465910 @default.
• W2022073464 cites W2109653150 @default.
• W2022073464 cites W2112069616 @default.
• W2022073464 cites W2113287405 @default.
• W2022073464 cites W2116813877 @default.
• W2022073464 cites W2117089606 @default.
• W2022073464 cites W2123363005 @default.
• W2022073464 cites W2124463063 @default.
• W2022073464 cites W2127446775 @default.
• W2022073464 cites W2130826590 @default.
• W2022073464 cites W2132654668 @default.
• W2022073464 cites W2134638467 @default.
• W2022073464 cites W2141579931 @default.
• W2022073464 cites W2143467222 @default.
• W2022073464 cites W2145308813 @default.
• W2022073464 cites W2148586726 @default.
• W2022073464 cites W2151507811 @default.
• W2022073464 cites W2153935963 @default.
• W2022073464 cites W2155464214 @default.
• W2022073464 cites W2155599713 @default.
• W2022073464 cites W2155995527 @default.
• W2022073464 cites W2156253417 @default.
• W2022073464 cites W2160834915 @default.
• W2022073464 cites W2161550811 @default.
• W2022073464 cites W2163184777 @default.
• W2022073464 cites W2164433065 @default.
• W2022073464 cites W2164918836 @default.

• next